4 participants
Open-Label, 48-Week Extension Study of Elvucitabine in Combination With Background Antiretroviral Therapy (ART) for Participants Who Have Completed Study ACH443-014A
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2023-08-14
- Start Date:
- 2006-09-30
- Completion:
- 2008-12-31
Conditions
- Human Immunodeficiency Virus (HIV)-1 Infection
Interventions
- DRUG
No Results Yet